PPGN
Polypeptide Group AG
Stock SIX Swiss Exchange – Stock Market Prices, News & Analysis
Company engaged in the development, manufacturing, and marketing of peptides and proteins for the pharmaceutical and cosmetic industries.
Polypeptide Group AG
PPGN
Company engaged in the development, manufacturing, and marketing of peptides and proteins for the pharmaceutical and cosmetic industries.
Price history of Polypeptide Group AG
Price history of Polypeptide Group AG
Performance & Momentum
Strategic Analysis
Polypeptide Group AG • 2026
Polypeptide Group AG positions itself as a specialized player in the development and production of peptides and proteins for the pharmaceutical and cosmetic sectors. Its differentiation is based on advanced expertise in biotechnology and its ability to address innovative high-value niches in healthcare and laboratories.
- Advanced technological mastery in peptides and proteins
- Integrated presence across multiple healthcare and cosmetic segments
- Growth potential supported by the increasing demand for specific biomolecules
- Significant volatility in the medium term that may reflect sensitivity to biotech cycles
- Limited European positioning compared to major global players
Recent momentum shows a marked recovery over the past year, signaling a resurgence of investor interest linked to clearer growth prospects. However, the moderate scoring suggests that the value remains subject to fluctuations, requiring vigilance regarding the evolution of market developments and commercial validation.
Similar stocks to Polypeptide Group AG
Take control
of your investments
Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.
- Real-time multi-portfolio tracking
- AI analysis of your positions
- Counter your cognitive biases
